Drug intelligence / Profile preview

curcumol

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intragastric
01

Overview

**Curcumol** is a natural sesquiterpenoid compound of the guaiane-type hemiketal class, predominantly extracted from the essential oil of Curcumae Rhizoma and found in species such as Curcuma wenyujin, Curcuma aromatica, and Curcuma longa. It is a bioactive molecule used in traditional Chinese medicine, particularly for its anti-cancer, hepatoprotective, anti-inflammatory, anti-viral, and anti-convulsant properties[3][5][8]. Pharmacological studies have shown curcumol’s tumor-suppressive activity in cancers including hepatocellular carcinoma, nasopharyngeal carcinoma, lung adenocarcinoma, ovarian, pancreatic, and breast cancer, as well as regulatory effects in liver fibrosis and viral infections. It acts by modulating cellular apoptotic pathways, immune responses (such as IFN-β secretion), and, based on recent research, allosteric modulation of GABA(A) receptors in neuronal cells[9]. Curcumol is under investigation for various cancers and liver diseases, but it is not an approved pharmaceutical drug in any major regulatory market[5][3].

Other names
curcumol(-)-curcumol(1S,2S,5S,8R,9S)-2-methyl-6-methylidene-9-propan-2-yl-11-oxatricyclo[6.2.1.01,5]undecan-8-ol(3S,3aS,5S,6R,8aS)-octahydro-3-methyl-8-methylene-5-(1-methylethyl)-6H-3a,6-epoxyazulen-6-ol5,8-epoxy-10(14)-guaien-8-ol6H-3a,6-epoxyazulen-6-ol, octahydro-3-methyl-8-methylene-5-(1-methylethyl)-, (3S,3aS,5S,6R,8aS)-9190RTN07X
02

Targets

IFN-β (Interferon beta)CASP3 (Caspase-3)

Beyond the preview

Go deeper on curcumol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on curcumol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call